Medications

Xtoro approved for swimmer's ear

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Oncology & Cancer

Why placebos for chemotherapy side effects are hard to swallow

It's unthinkable to give a placebo to someone to treat their cancer, but could we use one to treat chemotherapy's well-known side effects? Unfortunately, we may never be able to answer this question because the biggest obstacle ...

Medications

FDA: Akynzeo approved for chemo-related nausea / vomiting

(HealthDay)—The combination drug Akynzeo (netupitant and palonosetron) has been approved by the U.S. Food and Drug Administration to treat nausea and vomiting among people undergoing chemotherapy, the agency said Friday ...

Medications

Propofol use in execution stirs concern

The potential use of propofol in a Missouri execution next month is raising concerns that the anti-death penalty European Union could limit its export, endangering the supply of the vital anesthetic to thousands of hospitals ...

Surgery

Dual epidural analgesia most effective for scoliosis surgery

(HealthDay)—Dual continuous epidural analgesia (CEA) is the most effective pain control method following surgery for adolescent idiopathic scoliosis, according to a study published in the Sept. 1 issue of Spine.

Other

Epidural during/Post spine surgery gives better outcomes

(HealthDay)—In patients undergoing reconstructive spine surgery, combined epidural and general anesthesia results in better pain control and other outcomes compared with general anesthesia plus narcotics, according to a ...

Medications

Xgeva approved for rare, non-malignant tumor

(HealthDay)—Xgeva (denosumab) has been approved by the U.S. Food and Drug Administration to treat giant cell tumor of the bone (GCTB), a rare tumor that's most often non-cancerous.

page 6 from 18